During the past decade, Fundacja SYNAPSIS ul. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacja SYNAPSIS ul." #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundacja SYNAPSIS ul." are "Autism Spectrum Disorder (ASD)" (2 trials). Many other conditions were trialed in "Fundacja SYNAPSIS ul." in a lesser frequency.

Most popular intervention types in "Fundacja SYNAPSIS ul." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BUMETANIDE/S95008" (1 trials), "Bumetanide Oral Solution" (1 trials), "PLACEBO" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacja SYNAPSIS ul." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundacja SYNAPSIS ul.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundacja SYNAPSIS ul., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacja SYNAPSIS ul., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".